Literature DB >> 12444967

Site-specific modification of functional groups in genomic hepatitis delta virus (HDV) ribozyme.

Fumiko Nishikawa1, Miho Shirai, Satoshi Nishikawa.   

Abstract

Human hepatitis delta (HDV) ribozyme is one of small ribozymes, such as hammerhead and hairpin ribozymes, etc. Its secondary structure shows pseudoknot structure composed of four stems (I to IV) and three single-stranded regions (SSrA, -B and -C). The 3D structure of 3'-cleaved product of genomic HDV ribozyme provided extensive information about tertiary hydrogen bonding interactions between nucleotide bases, phosphate oxygens and 2'OHs including new stem structure P1.1. To analyze the role of these hydrogen bond networks in the catalytic reaction, site-specific atomic-level modifications (such as deoxynucleotides, deoxyribosyl-2-aminopurine, deoxyribosylpurine, 7-deaza-ribonucleotide and inosine) were incorporated in the smallest trans-acting HDV ribozyme (47-mer). Kinetic analysis of these ribozyme variants demonstrated the importance of the two W-C base pairs of P1.1 for cleavage; in addition, the results suggest that all hydrogen bond interactions detected in the crystal structure involving 2'-OH and N7 atoms are present in the active ribozyme structure. In most of the variants, the relative reduction in kobs caused by substitution of the 2'-OH group correlated with the number of hydrogen bonds affected by the substitution. However G74 and C75 may have more than one hydrogen bond involving the 2'-OH in both the trans- and cis-acting HDV ribozyme. Moreover, in variants in which N7 was deleted, kobs was reduced 5- to 15-fold, it may suggest that N7 assists in coordinating Mg2+ ions or water molecules which bind with weak affinity in the active structure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444967     DOI: 10.1046/j.1432-1033.2002.03280.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  A general method for rapid and nondenaturing purification of RNAs.

Authors:  Jeffrey S Kieft; Robert T Batey
Journal:  RNA       Date:  2004-06       Impact factor: 4.942

Review 2.  Two distinct catalytic strategies in the hepatitis δ virus ribozyme cleavage reaction.

Authors:  Barbara L Golden
Journal:  Biochemistry       Date:  2011-10-17       Impact factor: 3.162

3.  Monitoring of an RNA multistep folding pathway by isothermal titration calorimetry.

Authors:  Cédric Reymond; Martin Bisaillon; Jean-Pierre Perreault
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

4.  Determination of hepatitis delta virus ribozyme N(-1) nucleobase and functional group specificity using internal competition kinetics.

Authors:  Daniel L Kellerman; Kandice S Simmons; Mayra Pedraza; Joseph A Piccirilli; Darrin M York; Michael E Harris
Journal:  Anal Biochem       Date:  2015-05-01       Impact factor: 3.365

5.  A Two-Metal-Ion-Mediated Conformational Switching Pathway for HDV Ribozyme Activation.

Authors:  Tai-Sung Lee; Brian K Radak; Michael E Harris; Darrin M York
Journal:  ACS Catal       Date:  2016-02-01       Impact factor: 13.084

6.  Characterization of the Structure and Dynamics of the HDV Ribozyme at Different Stages Along the Reaction Path.

Authors:  Tai-Sung Lee; George Giambaşu; Michael E Harris; Darrin M York
Journal:  J Phys Chem Lett       Date:  2011-10-20       Impact factor: 6.475

7.  A catalytic metal ion interacts with the cleavage Site G.U wobble in the HDV ribozyme.

Authors:  Jui-Hui Chen; Bo Gong; Philip C Bevilacqua; Paul R Carey; Barbara L Golden
Journal:  Biochemistry       Date:  2009-02-24       Impact factor: 3.162

8.  Unbiased in vitro selection reveals the unique character of the self-cleaving antigenomic HDV RNA sequence.

Authors:  Atef Nehdi; Jean-Pierre Perreault
Journal:  Nucleic Acids Res       Date:  2006-01-23       Impact factor: 16.971

Review 9.  Modulating RNA structure and catalysis: lessons from small cleaving ribozymes.

Authors:  Cedric Reymond; Jean-Denis Beaudoin; Jean-Pierre Perreault
Journal:  Cell Mol Life Sci       Date:  2009-08-30       Impact factor: 9.261

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.